Does PERTUZUMAB Cause Breast cancer? 188 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 188 reports of Breast cancer have been filed in association with PERTUZUMAB (PERJETA). This represents 0.9% of all adverse event reports for PERTUZUMAB.
188
Reports of Breast cancer with PERTUZUMAB
0.9%
of all PERTUZUMAB reports
55
Deaths
44
Hospitalizations
How Dangerous Is Breast cancer From PERTUZUMAB?
Of the 188 reports, 55 (29.3%) resulted in death, 44 (23.4%) required hospitalization, and 11 (5.9%) were considered life-threatening.
Is Breast cancer Listed in the Official Label?
Yes, Breast cancer is listed as a known adverse reaction in the official FDA drug label for PERTUZUMAB.
What Other Side Effects Does PERTUZUMAB Cause?
Diarrhoea (3,343)
Off label use (1,886)
Fatigue (1,672)
Nausea (1,669)
Myelosuppression (1,311)
Disease progression (1,142)
Vomiting (1,096)
Dyspnoea (987)
Neuropathy peripheral (983)
Pyrexia (926)
What Other Drugs Cause Breast cancer?
RANITIDINE (45,666)
LETROZOLE (1,393)
ETANERCEPT (1,303)
METHOTREXATE (936)
ADALIMUMAB (894)
INFLIXIMAB (789)
RIBOCICLIB (788)
FULVESTRANT (684)
DENOSUMAB (671)
ABATACEPT (617)
Which PERTUZUMAB Alternatives Have Lower Breast cancer Risk?
PERTUZUMAB vs PERTUZUMAB\TRASTUZUMAB
PERTUZUMAB vs PETROLATUM
PERTUZUMAB vs PEVONEDISTAT
PERTUZUMAB vs PEXIDARTINIB
PERTUZUMAB vs PHENACETIN